Table 1.
Comments and Physician Opinions by Country Regarding Patient Subpopulations Whose Treatment Is Most Likely Affected by the Lockdown
| Country | Comment |
|---|---|
| Algeria | Patients with sarcomas and low‐grade gliomas who have weekly treatment regimen |
| Iran | Patients from northern provinces |
| Iraq | New cases of leukemia or lymphoma or unresponsive anemia |
| Iraq | Those who are living in the peripheral areas outside the city center |
| Jordan | Some patients who are off therapy and are worried about coming to the hospital |
| KSA | Solid tumor, lymphomas, leukemias, stem cell transplantation recipients |
| KSA | Patients requiring BMT were particularly affected |
| Kuwait | Patients who have brain tumors because of comorbidities after treatment are affected most |
| Lebanon | International patients who receive part of their therapy at our center, such as patients with retinoblastoma from Syria and Iraq |
| Lebanon | Low‐risk patients; some high‐risk patients who need chemotherapy that became unavailable because of the lockdown |
| Morocco | Patients with solid tumors (delays in surgery and/or radiation therapy) |
| Nepal | Mostly patients with hematologic malignancies are suffering more because they must wait to receive diagnosis and treatment |
| Pakistan | Newly diagnosed patients; further delay in initial diagnosis as public transport is stopped and diagnostic procedures are delayed; visits are very limited, and multidisciplinary tumor boards are also affected |
| Pakistan | Patients with Hodgkin lymphoma who live outside the city, whereas others live in the city during treatment |
| Pakistan | Pretransplantation visits are delayed because of family concern of infection |
| Sudan | Patients with febrile neutropenia and patients requiring supportive care (antibiotics, blood products, growth factors, etc) |
| Syria | Patients who need part of their treatment outside the country |
| Syria | Chemotherapy visits are delayed for 1 week for nonhigh–risk patients in complete remission |
| Turkey | Stem cell transplantation is suspended at our center because of blood product supplies, unless there is an urgent indication (leukemia, immunodeficiency) |
| Yemen | Because of the lockdown between cities in the north and south, some patients cannot travel to the referral center for treatment |
Abbreviations: BMT, bone marrow transplantation; KSA, Kingdom of Saudi Arabia.